26
|
Bottiroli M, Pinciroli R, Monti G, Mininni M, Casella G, Fumagalli R. Prevalence and clinical significance of early endotoxin activity in septic shock patients. Crit Care 2015. [PMCID: PMC4472797 DOI: 10.1186/cc14128] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/04/2022] Open
|
27
|
Quartuccio L, Zuliani F, Corazza L, Scaini P, Zani R, Lenzi M, Tavoni A, Sebastiani M, Baldovino S, Urraro T, Saccardo F, Sbreglia C, Mazzaro C, Pioltelli P, Fraticelli P, Filippini D, Gabrielli A, Perrella O, Scarpato S, Roccatello D, Zignego A, Ferri C, Bombardieri S, Pietrogrande M, Galli M, Monti G, De Vita S. OP0228 Rituximab Monotherapy of Severe Hcv-Related Cryoglobulinemic Vasculitis for More than 2 Years: Follow-Up of A Randomized Controlled Multicentre Study. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2014-eular.3872] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
28
|
Azócar-Aedo L, Smits HL, Monti G. Leptospirosis in dogs and cats: epidemiology, clinical disease, zoonotic implications and prevention. ACTA ACUST UNITED AC 2014. [DOI: 10.4067/s0301-732x2014000300002] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
29
|
Vallerio P, Belli O, Musca F, Monti G, Bonacchini L, Cazzaniga M, Stucchi M, Meani P, Frigerio L, Molteni M, Panzeri F, Alloni M, Fumagalli R, De Gasperi A, Giannattasio C. P7.2 IDENTIFICATION OF VASCULAR AND CIRCULATING BIOMARKERS TO PREDICT OUTCOME IN PATIENTS AFFECTED BY SEPTIC SHOCK. Artery Res 2014. [DOI: 10.1016/j.artres.2014.09.164] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
30
|
Spagnolo E, Benfenati A, Di Donato N, Montanari G, Monti G, Giovanardi G, Bertoldo V, Leonardi D, Seracchioli R, Venturoli S. Quality of Sexual Life in Women with Deep Infiltrating Endometriosis: A Case-Control Study. J Minim Invasive Gynecol 2013. [DOI: 10.1016/j.jmig.2013.08.025] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
31
|
Kruze J, Monti G, Schulze F, Mella A, Leiva S. Herd-level prevalence of Map infection in dairy herds of southern Chile determined by culture of environmental fecal samples and bulk-tank milk qPCR. Prev Vet Med 2013; 111:319-24. [DOI: 10.1016/j.prevetmed.2013.05.011] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/18/2013] [Revised: 05/20/2013] [Accepted: 05/21/2013] [Indexed: 11/26/2022]
|
32
|
Atzeni F, Marchesoni A, Filippini M, Caporali R, Gorla R, Cavagna L, Favalli E, Monti G, Sarzi-Puttini P. FRI0072 Predictors of response to anti-TNF therapy in ra patients with moderate disease activity compared to those with high disease activity according to DAS28 scores’. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2012-eular.2529] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
33
|
Ingegnoli F, Gualtierotti R, Schioppo T, Orenti A, Boracchi P, Lubatti C, Murgo A, Zeni S, Mastaglio C, Galbiati V, Monti G, Grossi C, Borghi O, Rosenberg W, Meroni PL. FRI0403 How early starts increased collagen synthesis in systemic sclerosis? Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2013-eular.1530] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
34
|
De Vita S, Quartuccio L, Isola M, Corazza L, Ramos-Casals M, Retamozo S, Ragab G, Zoheir N, El Menyawi MM, Salem M, Sansonno D, Conteduca V, Ferraccioli G, Gremese E, Tzioufas A, Voulgarelis M, Vassilopoulos D, Koutsianas C, Zignego AL, Urraro T, Pipitone N, Salvarani C, Ghinoi A, Guillevin L, Terrier B, Cacoub P, Filippini D, Saccardo F, Gabrielli A, Fraticelli P, Tomsic M, Ferri C, Sebastiani M, Tavoni A, Catarsi E, Mazzaro C, Pioltelli P, Nishimoto N, Scaini P, Monti G, Pietrogrande M, Galli M, Bombardieri S. SAT0175 Results of the Classification Criteria for Cryoglobulinemic Vasculitis Validation Study. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2013-eular.1901] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
35
|
Pisanello F, De Paolis R, Lorenzo D, Guardia P, Nitti S, Monti G, Fragouli D, Athanassiou A, Tarricone L, Manna L, De Vittorio M, Martiradonna L. GHz properties of magnetophoretically aligned iron-oxide nanoparticle doped polymers. ACS APPLIED MATERIALS & INTERFACES 2013; 5:2908-2914. [PMID: 23537058 DOI: 10.1021/am400239b] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/02/2023]
Abstract
We show that assembled domains of magnetic iron-oxide nanoparticles (IONPs) are effective at increasing the dielectric permittivity of polydimethylsiloxane (PDMS) nanocomposites in the GHz frequency range. The assembly has been achieved by means of magnetophoretic transport and its efficacy, as well as the electromagnetic properties of the nanocomposite, has been found to depend on IONPs diameter. Remarkably, the dielectric permittivity increase has been obtained by keeping dielectric and magnetic losses very low, making us envision the suitability of nanocomposites based on aligned IONPs as substrates for radiofrequency applications.
Collapse
|
36
|
Calini AR, Vesconi S, Fumagalli R, Marchesi S, Ghezzi L, Monti G. Fighting hospital sepsis. Crit Care 2013. [PMCID: PMC3642961 DOI: 10.1186/cc11993] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
37
|
Landoni G, Pasin L, Monti G, Cabrini L, Beretta L, Zangrillo A. Towards zero perioperative mortality. HEART, LUNG AND VESSELS 2013; 5:133-6. [PMID: 24364003 PMCID: PMC3848670] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
|
38
|
Ferrari R, Giostra F, Agostinelli D, Monti G, Pomata DP, Cavazza M. Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease in the emergency department: early predictors of in-hospital outcome. EMERGENCY CARE JOURNAL 2012. [DOI: 10.4081/ecj.2012.2.43] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
|
39
|
De Vita S, Quartuccio L, Isola M, Mazzaro C, Scaini P, Lenzi M, Campanini M, Naclerio C, Tavoni A, Pietrogrande M, Ferri C, Mascia MT, Masolini P, Zabotti A, Maset M, Roccatello D, Zignego AL, Pioltelli P, Gabrielli A, Filippini D, Perrella O, Migliaresi S, Galli M, Bombardieri S, Monti G. A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis. ACTA ACUST UNITED AC 2012; 64:843-53. [PMID: 22147661 DOI: 10.1002/art.34331] [Citation(s) in RCA: 257] [Impact Index Per Article: 21.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Abstract
OBJECTIVE To conduct a long-term, prospective, randomized controlled trial evaluating rituximab (RTX) therapy for severe mixed cryoglobulinemia or cryoglobulinemic vasculitis (CV). METHODS Fifty-nine patients with CV and related skin ulcers, active glomerulonephritis, or refractory peripheral neuropathy were enrolled. In CV patients who also had hepatitis C virus (HCV) infection, treatment of the HCV infection with antiviral agents had previously failed or was not indicated. Patients were randomized to the non-RTX group (to receive conventional treatment, consisting of 1 of the following 3: glucocorticoids; azathioprine or cyclophosphamide; or plasmapheresis) or the RTX group (to receive 2 infusions of 1 gm each, with a lowering of the glucocorticoid dosage when possible, and with a second course of RTX at relapse). Patients in the non-RTX group who did not respond to treatment could be switched to the RTX group. Study duration was 24 months. RESULTS Survival of treatment at 12 months (i.e., the proportion of patients who continued taking their initial therapy), the primary end point, was statistically higher in the RTX group (64.3% versus 3.5% [P < 0.0001]), as well as at 3 months (92.9% versus 13.8% [P < 0.0001]), 6 months (71.4% versus 3.5% [P < 0.0001]), and 24 months (60.7% versus 3.5% [P < 0.0001]). The Birmingham Vasculitis Activity Score decreased only after treatment with RTX (from a mean ± SD of 11.9 ± 5.4 at baseline to 7.1 ± 5.7 at month 2; P < 0.001) up to month 24 (4.4 ± 4.6; P < 0.0001). RTX appeared to be superior therapy for all 3 target organ manifestations, and it was as effective as conventional therapy. The median duration of response to RTX was 18 months. Overall, RTX treatment was well tolerated. CONCLUSION RTX monotherapy represents a very good option for severe CV and can be maintained over the long term in most patients.
Collapse
|
40
|
Monti G, Viola S, Baro C, Cresi F, Tovo PA, Moro G, Ferrero MP, Conti A, Bertino E. Tolerability of donkey's milk in 92 highly-problematic cow's milk allergic children. J BIOL REG HOMEOS AG 2012; 26:75-82. [PMID: 23158519] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Abstract
OBJECTIVE Not exclusively breastfed children with cow's milk allergy (CMA) require a formula or other alternative food, but past and present guidelines differ concerning the best choice. Our aim was to investigate the clinical tolerability, palatability and nutritional adequacy of donkey's milk (DM) in children with proven CMA. It was important to identify a CM replacement for these children, highly problematic from the feeding standpoint, in spite of their age. STUDY DESIGN A prospective study was conducted on 92 children with CMA, diagnosed through a CM elimination diet, followed by double-blind, placebo-controlled food challenge (DBPCFC) unless contraindicated. Maternal milk was unavailable and current CM substitutes could not be used. Moreover, 89 percent were affected by multiple FA, and subjected to very restricted diets. Within 3 months after the last CM challenge, DBPCFC for DM was performed. CM or DM skin prick test and sIgE determination preceded the CM or DM challenge, respectively. Native electrophoresis and immunoblotting were used to identify CM and DM cross-reactive proteins. Z-scores of weight and length/stature for age were calculated at DM food challenge (T0) and during DM assumption. RESULTS 83 children (90.2 percent) liked and tolerated DM, at challenge and during follow-up, with increased Z-score for weight and length/stature and improved nutritional parameters. Bovine beta-lactoglobulin was identified as the cross-reacting protein among the DM allergic patients. CONCLUSIONS DM was found to be a valid alternative foodstuff, in terms of clinical tolerability, palatability and nutritional adequacy, in subjects with CMA who were highly problematic from the feeding standpoint.
Collapse
|
41
|
Cecconi M, Monti G, Hamilton MA, Puntis M, Dawson D, Tuccillo ML, Della Rocca G, Grounds RM, Rhodes A. Efficacy of functional hemodynamic parameters in predicting fluid responsiveness with pulse power analysis in surgical patients. Minerva Anestesiol 2012; 78:527-533. [PMID: 22534733] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
Abstract
BACKGROUND In this study we quantify the ability of dynamic cardiovascular parameters measured by the PulseCO™ algorithm of the LiDCO™plus monitor to predict the response to a fluid challenge in post-operative patients. METHODS Surgical patients, admitted to the Intensive Care Unit from the operating theatre were monitored with the LiDCO™plus system. A number of static and dynamic cardiovascular measurements were recorded before and after a fluid challenge. Receiver Operator Characteristic (ROC) curve analysis was used to identify the baseline values, with optimum sensitivity and specificity, to predict responsiveness to a fluid challenge. RESULTS Thirty-one patients were enrolled, and received protocol-based fluid challenges. Twelve (38%) responded by demonstrating an increase in stroke volume of >15%. Heart rate (HR) and central venous pressure (CVP) were not statistically different between responders and non-responders. Mean arterial pressure (mAP), systolic pressure variation (SPV), pulse pressure variation (PPV) and stroke volume variation (SVV) were statistically different between responders and non-responders. Parameters with a ROC area under the curve (AUC) significantly >0.5 included SPV 0.70 (0.52-0.88) P=0.046, PPV 0.87 (0.76-0.99) P<0.0002 and SVV 0.84 (0.71-0.96) P=0.0005. The best cut-off values (sensitivity and specificity) to predict fluid were SPV >9 mmHg (73%, 76%), PPV >13% (83%, 74%) and SVV >12.5% (75%, 83%). ROC analysis did not show the AUC to be significantly >0.5 for HR, mAP and CVP CONCLUSION: Dynamic indices measured by PulseCO™ (LiDCO) have a high sensitivity and specificity in predicting fluid responsiveness in sedated and mechanically ventilated patients. A cut-off value for PPV of 13% is the most sensitive and specific indicator of fluid responsiveness.
Collapse
|
42
|
Catarinucci L, Monti G, Tarricone L. METAL FOAMS FOR ELECTROMAGNETICS: EXPERIMENTAL, NUMERICAL AND ANALYTICAL CHARACTERIZATION. ACTA ACUST UNITED AC 2012. [DOI: 10.2528/pierb12082913] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
43
|
Ghio FE, Serini C, Ghislanzoni L, Calini A, Monti G, Pappalardo F, Ponti A. 2012 pandemic flu. HSR PROCEEDINGS IN INTENSIVE CARE & CARDIOVASCULAR ANESTHESIA 2012; 4:271. [PMID: 23441289 PMCID: PMC3563562] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
|
44
|
Abstract
UNLABELLED White potato is a very common ingredient in the diet of infants in Mediterranean countries, and in its cooked form, it is one of the first solid foods introduced, usually around the age of 4-6 months. Allergy to potato is uncommon, and allergic reactions to cooked potato have been reported only in children. We report a case of severe potato-induced allergic reaction in an 8-month-old infant with atopic dermatitis and multiple food allergies that raises questions about differential diagnosis between anaphylaxis and food protein-induced enterocolitis syndrome (FPIES). CONCLUSION Allergy to cooked potatoes could be a cause of severe although rare allergic reactions; it could be very difficult, in some cases, to make a differential diagnosis between anaphylaxis and FPIES. Moreover, the diagnosis appears to be very important for the choice of therapy and long-term allergologic management.
Collapse
|
45
|
De Vita S, Soldano F, Isola M, Monti G, Gabrielli A, Tzioufas A, Ferri C, Ferraccioli GF, Quartuccio L, Corazza L, De Marchi G, Ramos Casals M, Voulgarelis M, Lenzi M, Saccardo F, Fraticelli P, Mascia MT, Sansonno D, Cacoub P, Tomsic M, Tavoni A, Pietrogrande M, Zignego AL, Scarpato S, Mazzaro C, Pioltelli P, Steinfeld S, Lamprecht P, Bombardieri S, Galli M. Preliminary classification criteria for the cryoglobulinaemic vasculitis. Ann Rheum Dis 2011; 70:1183-90. [PMID: 21571735 PMCID: PMC3103668 DOI: 10.1136/ard.2011.150755] [Citation(s) in RCA: 105] [Impact Index Per Article: 8.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
Abstract
Background To develop preliminary classification criteria for the cryoglobulinaemic syndrome or cryoglobulinaemic vasculitis (CV). Methods Study part I developed a questionnaire for CV to be included in the formal, second part (study part II). Positivity of serum cryoglobulins was defined by experts as an essential condition for CV classification. In study part II, a core set of classification items (questionnaire, clinical and laboratory items, as agreed) was tested in three groups of patients and controls—that is, group A (new patients with the CV), group B (controls with serum cryoglobulins but lacking CV) and group C (controls without serum cryoglobulins but with features which can be observed in CV). Results In study part I (188 cases, 284 controls), a positive response to at least two of three selected questions showed a sensitivity of 81.9% and a specificity of 83.5% for CV. This questionnaire was employed and validated in study part II, which included 272 patients in group A and 228 controls in group B. The final classification criteria for CV, by pooling data from group A and group B, required the positivity of questionnaire plus clinical, questionnaire plus laboratory, or clinical plus laboratory items, or all the three, providing a sensitivity of 88.5% and a specificity of 93.6% for CV. By comparing data in group A versus group C (425 controls), the same classification criteria showed a sensitivity 88.5% and a specificity 97.0% for CV. Conclusion Classification criteria for CV were developed, and now need validation.
Collapse
|
46
|
Monti G, Cosentino V, Castagno E, Nebiolo F. Anaphylaxis caused by Crematogaster cutellaris sting in an Italian child. J Investig Allergol Clin Immunol 2011; 21:576-577. [PMID: 22312947] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/31/2023] Open
|
47
|
Olper L, Cabrini L, Landoni G, Rossodivita A, Nobile L, Monti G, Alfieri O, Zangrillo A. Non-invasive ventilation after cardiac surgery outside the Intensive Care Unit. Minerva Anestesiol 2011; 77:40-45. [PMID: 21150853] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
Abstract
BACKGROUND Non-invasive ventilation (NIV) can prevent or treat postoperative acute respiratory failure. NIV after discharge from the Intensive Care Unit (ICU) has never been described in the setting of cardiac surgery. METHODS This study enrolled 85 patients who received NIV in the main ward as treatment for respiratory failure. The patients had the following conditions: atelectasis (45 patients), pleural effusion (20 patients), pulmonary congestion (13 patients), diaphragm hemiparesis (6 patients), pneumonia (4 patients) or a combination of these conditions. RESULTS Eighty-three patients were discharged from the hospital in good condition and without need for further NIV treatment, while two died in-hospital. Four of the 85 patients had an immediate NIV failure, while eight patients had delayed NIV failure. Only one patient had a NIV-related complication represented by hypotension after NIV institution. In this patient, NIV was interrupted with no consequences. Major mistakes were mask malpositioning with excessive air leaks (7 patients), incorrect preparation of the circuit (one patient), and oxygen tube disconnection (one patient). Minor mistakes (sub-optimal positioning of the face mask without excessive air leaks) were noted by the respiratory therapists for all patients and were managed by slightly modifying the mask position. CONCLUSION In our experience, postoperative NIV is feasible, safe and effective in treating postoperative acute respiratory failure when applied in the cardiac surgical ward, preserving intensive care unit beds for surgical activity. A respiratory therapy service managed the treatment in conjunction with ward nurses, while an anesthesiologist and a cardiologist served as consultants.
Collapse
|
48
|
Moen CA, Salminen PR, Grong K, Matre K, Pawlak A, Gziut AI, Brudek M, Gil RJ, Varela A, Mavroeidis M, Psaras S, Rapti C, Soumaka E, Panagopoulou P, Capetanaki Y, Davos CH, Coppola C, Tocchetti CG, Ragone G, Monti G, Palma G, Cittadini A, Arra C, De Lorenzo C, Iaffaioli RV, Maurea N, Dedobbeleer C, Deboeck G, Lamotte M, Naeije R, Unger P. Oral session II: Advances in basic pathophysiology * Thursday 9 December 2010, 11:00-12:30. EUROPEAN JOURNAL OF ECHOCARDIOGRAPHY 2010. [DOI: 10.1093/ejechocard/jeq132] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
49
|
Cabrini L, Silvani P, Landoni G, Monti G, Colombo S, Zangrillo A. Monitoring non-invasive ventilation outside the intensive care unit. Minerva Anestesiol 2010; 76:71-72. [PMID: 20125077] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/28/2023]
|
50
|
Cecconi M, Monti G, Vesconi S, Hamilton M, Grounds M, Rhodes A. NICOM vs LiDCO™ plus during changes in cardiac output in critically ill patients. Crit Care 2010. [PMCID: PMC2934558 DOI: 10.1186/cc8332] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
|